Source: Viruses ISSN:1999-4915. Unidade: ICB
Subjects: MICROBIOLOGIA, CATÁLISE, ANTIVIRAIS, COVID-19, CORONAVIRUS, INIBIDORES DE ENZIMAS
ABNT
AMORIM, Vitor Martins de Freitas et al. 3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: validation as a molecular target, proposal of a novel catalytic mechanism, and inhibitors in preclinical and clinical trials. Viruses ISSN:1999-4915, v. 16, n. 6, p. 22 , 2024Tradução . . Disponível em: https://doi.org/10.3390/v16060844. Acesso em: 17 out. 2024.APA
Amorim, V. M. de F., Soares, E. P., Ferrari, A. S. de A., Merighi, D. G. S., Souza, A. S. de, Souza, R. F. de, & Carvalho, C. R. G. (2024). 3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: validation as a molecular target, proposal of a novel catalytic mechanism, and inhibitors in preclinical and clinical trials. Viruses ISSN:1999-4915, 16( 6), 22 . doi:10.3390/v16060844NLM
Amorim VM de F, Soares EP, Ferrari AS de A, Merighi DGS, Souza AS de, Souza RF de, Carvalho CRG. 3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: validation as a molecular target, proposal of a novel catalytic mechanism, and inhibitors in preclinical and clinical trials [Internet]. Viruses ISSN:1999-4915. 2024 ; 16( 6): 22 .[citado 2024 out. 17 ] Available from: https://doi.org/10.3390/v16060844Vancouver
Amorim VM de F, Soares EP, Ferrari AS de A, Merighi DGS, Souza AS de, Souza RF de, Carvalho CRG. 3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: validation as a molecular target, proposal of a novel catalytic mechanism, and inhibitors in preclinical and clinical trials [Internet]. Viruses ISSN:1999-4915. 2024 ; 16( 6): 22 .[citado 2024 out. 17 ] Available from: https://doi.org/10.3390/v16060844